Several of our research teams have been successful in receiving funding recently; these grants allow us to leverage existing funding and secure further large-scale investment. We are particularly appreciative of grants we have received over the past 8 months given the impact COVID-19 has had on grant availability.

Prof Hugh McDermott leads a team using a novel brain signal to create a device that will radically improve deep brain stimulation therapy for Parkinson’s disease patients. This research has received support from two Government grants; the Victorian Medical Research Acceleration Fund and the Biomedical Translation Bridge program which forms part of the Medical Research Future Fund.

A/Prof Andrew Wise and his team were successful in being awarded a National Health and Medical Research Council Development Grant to support the development of a novel technology that may be able to stop the progression of hearing loss.

Our tinnitus research team led by Dr Mehrnaz Shoushtarian received support from the Medical Device Partnering Program to further her development of an objective measure of tinnitus.

Prof Colette McKay and her team received additional support through the BioMedTech horizons grant scheme to assist with the clinical translation of EarGenie™: a system for personalised management of hearing impairment for infants.

A/Prof Fallon and his team in collaboration with Prof Janet Keast from University of Melbourne were successful in receiving further funding from the National Institutes of Health (USA) grant to develop the urinary incontinence device to modulate sensory and motor pathways to the bladder.